Negative / Null Result ReportOpen accessMedicine

Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study

Luis M. Pérez-Belmonte; José David Torres-Peña; María D. López-Carmona; M. Mar. Ayala-Gutiérrez; Francisco Fuentes-Jiménez; Lucía Jorge Huerta; Jaime Alonso Muñoz; Manuel Rubio-Rivas · 2020 · BMC Medicine

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

Abstract Background Limited evidence exists on the role of glucose-lowering drugs in patients with COVID-19. Our main objective was to examine the association between in-hospital death and each routine at-home glucose-lowering drug both individually and in combination with metformin in patients with type 2 diabetes mellitus admitted for COVID-19. We also evaluated their association with the composite outcome of the need for ICU admission, invasive and non-invasive mechanical ventilation, or in-hospital death as well as on the development of in-hospital complications and a long-time hospital st

Abstract by Luis M. Pérez-Belmonte; José David Torres-Peña; María D. López-Carmona; M. Mar. Ayala-Gutiérrez; Francisco Fuentes-Jiménez; Lucía Jorge Huerta; Jaime Alonso Muñoz; Manuel Rubio-Rivas, BMC Medicine (2020) — licensed CC BY 4.0.

Read the full paper (open access)